GSKCONS

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on February 15, 2013, inter alia, has recommended a Dividend at the rate of Rs. 45 per equity share of Rs. 10 each.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange that the dividend shall be paid to the entitled Members on or before May 08, 2013.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on February 15, 2013 has transacted the following:(1) Re-appointed Mr. Zubair Ahmed as Managing Director of the Company for the period from June 01, 2013 to May 31, 2017. Mr. Zubair Ahmed's terms of appointment and remuneration are subject to the approval of the shareholders.(2). The Board also approved the change in Financial Year of the Company from Calendar Year to Financial Year w.e.f. January 01, 2013 to March 31, 2014 and thereafter the Financial Year will

GlaxoSmithKline Consumer Healthcare Limited has submitted to the Exchange the Standalone Financial Results for the period ended December 31,2012.

HSBC Securities and Capital Markets (India) Private Limited has submitted to the Exchange a Copy of post offer opening advertisement under Regulation 18(7) in terms of SEBI (SAST) Regulations, 2011 was published in newspapers on January 16, 2013.

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange a copy of Recommendations of the Committee of Independent Director (IDC) on the Open Offer to the Shareholders of Company under Regulation 26(7) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

HSBC Securities and Capital Markets (India) Private Limited has informed the Exchange regarding Voluntary Open Offer by GlaxoSmithKline Pte Ltd ("GSK Pte" or t he "Acquirer") along with Horlicks Limited ("Horlicks") and GlaxoSmithKline plc ("GSK plc") in their capacity as persons acting in concert (each entity individu ally referred to as "PAC" and together referred to as "PACs") with the Acquirer, to the equity shareholders of GlaxoSmithKline Consumer Healthcare Limited (the "Target Company") to acquire 13,389,410 equity shares ("Shares) of Rs. 10/- each representing 31.84% of the total Vo

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding the standalone Results for the quarter ended on 30-SEP-2012 as follows: Net Sales of Rs. 82754 lacs for the quarter ending on 30-SEP-2012 against Rs. 72973 lacs and Rs. 72007 lacs for the quarters ending on 30-JUN-2012 and 30-SEP-2011 respectively. Net Profit / (Loss) of Rs. 12855 lacs for the quarter ending on 30-SEP-2012 against Rs. 10660 lacs and Rs. 10303 lacs for the quarters ending on 30-JUN-2012 and 30-SEP-2011 respectively.

GlaxoSmithKline Consumer Healthcare Limited has submitted to the Exchange the Standalone Financial Results along with the Limited Review Report for the period ended September 30,2012.

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange a copy of Abstract for appointment and remuneration of Mr. Ramakrishnan Subramanian, Wholetime Director.

GlaxoSmithKline Consumer Healthcare Limited has submitted to the Exchange the Standalone Financial Results along with the Limited Review Report for the period ended June 30, 2012.

GlaxoSmithKline Consumer Healthcare Limited has submitted to the Exchange the Standalone Financial Results along with Limited Review Report for the period ended March 31,2012.

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange a copy of Minutes of the Annual General Meeting of the Company held on March 22, 2012.

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange a copy of the Proceedings of the Annual General Meeting of the Company held on March 22, 2012.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that the dividend shall be paid to the entitled Members on or before April 03, 2012.

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange a copy of annual declaration/ disclosure forms as received from employees of the Company under SEBI (Prohibition of Insider Trading) Regulations, 1992.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that the Register of Members and Share Transfer Books will remain closed from March 13, 2012 to March 22, 2012, both days inclusive, for the purpose of Dividend and the Annual General Meeting scheduled to be held on March 22, 2012.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that the Board of Directors of the Company at its meeting of the Company held on February 06, 2012 has appointed Mr. Jaiboy John Phillips as a Wholetime Director of the Company, w.e.f. February 06, 2012, in the casual vacancy caused by the resignation of Mr. Praveen K Gupta, Director - Operations.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on February 06, 2012 has recommended a Dividend at the rate of Rs. 35/- per equity share of Rs. 10 each.

GlaxoSmithKline Consumer Healthcare Limited has submitted to the Exchange the Standalone Financial Results for the period ended December 31,2011.

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange a copy of presentation which was made on November 29, 2011 by Managing Director to financial analysts.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that the Board of Directors has re-appointed Mr. Zubair Ahmed as Managing Director of the Company for the period from January 01, 2012 to May 31, 2013 as a Nominee of Horlicks Ltd., the Promoters of the Company. Mr. Zubair Ahmed's terms of appointment and remuneration are subject to the approval of the shareholders.

GlaxoSmithKline Consumer Healthcare Limited has submitted to the Exchange the Standalone Financial Results for the period ended September 30,2011.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding the standalone Results for the quarter ended on 30-JUN-2011 as follows: Net Sales of Rs. 65338 lacs for quarter ending on 30-JUN-2011 against Rs. 53735 lacs for the quarter ending on 30-JUN-2010. Net Profit / (Loss) of Rs. 8246 lacs for the quarter ending on 30-JUN-2011 against Rs. 7175 lacs for the quarter ending on 30-JUN-2010.

GlaxoSmithKline Consumer Healthcare Limited has submitted to the Exchange the Standalone Financial Results for the period ended June 30,2011.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding the standalone Results for the quarter ended on 31-MAR-2011 as follows: Net Sales of Rs. 71001 lacs for quarter ending on 31-MAR-2011 against Rs. 64843 lacs for the quarter ending on 31-MAR-2010. Net Profit / (Loss) of Rs. 11062 lacs for the quarter ending on 31-MAR-2011 against Rs. 9616 lacs for the quarter ending on 31-MAR-2010.

GlaxoSmithKline Consumer Healthcare Limited has submitted to the Exchange the Standalone Financial Results for the period ended March 31,2011.

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange a copy of Minutes of the Annual General Meeting of the Company held on March 29, 2011.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that at the Annual General Meeting of the Company held on March 29, 2011, all the items of business contained in the notice of the Annual General Meeting of the Company were approved by the Members, who : (1) Approved the Audited Balance Sheet and Profit and Loss account for the year ended December 31, 2010 together with the Directors' Report and Auditors Report thereon; (2) Approved and Declared a dividend of Rs. 50.00 per equity share of Rs.10 each for the year ended December 31, 2010; (3) Re-appointed of M/s. PriceWaterho

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange a copy of Notice of the Annual General Meeting of the Company to be held on March 29, 2011.

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange a copy of disclosure as per SEBI (Prohibition of Insider Trading) Regulations, 1992.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that the Register of Members and Share Transfer Books will remain closed from March 15, 2011 to March 28, 2011, both days inclusive, for the purpose of Dividend and Annual General Meeting. Further, the Annual General Meeting of the members of the Company will be held on March 29, 2011.

GlaxoSmithKline Consumer Healthcare Limited has submitted to the Exchange the Standalone Financial Results for the period ended December 31,2010.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding the standalone Results for the year ended on 31-DEC-2010 as follows: Net Sales of Rs. 230612 lacs for year ending on 31-DEC-2010 against Rs. 192150 lacs for the year ending on 31-DEC-2009. Net Profit / (Loss) of Rs. 29985 lacs for the year ending on 31-DEC-2010 against Rs. 23278 lacs for the year ending on 31-DEC-2009.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding the standalone Results for the quarter ended on 31-DEC-2010 as follows: Net Sales of Rs. 50776 lacs for quarter ending on 31-DEC-2010 against Rs. 41812 lacs for the quarter ending on 31-DEC-2009. Net Profit / (Loss) of Rs. 5337 lacs for the quarter ending on 31-DEC-2010 against Rs. 3368 lacs for the quarter ending on 31-DEC-2009.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on February 02, 2011 has recommended a Dividend at the rate of Rs. 50 per equity share of Rs.10 each (Dividend of Rs. 25 per equity share and a Special Dividend of Rs. 25 per equity share to celebrate Golden Jubilee of the Company).

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that "On 6th January, 2011 several newspapers carried Articles and interviews around launches of Sensodyne(R) Sensitive Toothpaste by GSK in India. We would like to clarify that the launch has been done by GSK Asia Private Ltd, our Associate Company in India and not by GlaxoSmithKline Consumer Healthcare Ltd. as reported in some newspapers".

GlaxoSmithKline Consumer Healthcare Limited has submitted to the Exchange the Standalone Financial Results for the period ended September 30,2010.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding the standalone Results for the quarter ended on 30-SEP-2010 as follows: Net Sales of Rs. 61258 lacs for quarter ending on 30-SEP-2010 against Rs. 49506 lacs for the quarter ending on 30-SEP-2009. Net Profit / (Loss) of Rs. 7857 lacs for the quarter ending on 30-SEP-2010 against Rs. 6002 lacs for the quarter ending on 30-SEP-2009.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding the standalone Results for the quarter ended on 30-JUN-2010 as follows: Net Sales of Rs. 53735 lacs for quarter ending on 30-JUN-2010 against Rs. 46872 lacs for the quarter ending on 30-JUN-2009. Net Profit / (Loss) of Rs. 7175 lacs for the quarter ending on 30-JUN-2010 against Rs. 5519 lacs for the quarter ending on 30-JUN-2009.

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange Minutes of the Annual General Meeting held on April 23, 2010.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange regarding the proceeding of Annual General Meeting held on April 23, 2010. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/gskcons_proceeds_23042010.zip target=NEW> For more details click here.</a>

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding the standalone Results for the quarter ended on 31-MAR-2010 as follows: Net Sales of Rs. 64843 lacs for quarter ending on 31-MAR-2010 against Rs. 53937 lacs for the quarter ending on 31-MAR-2009. Net Profit / (Loss) of Rs. 9616 lacs for the quarter ending on 31-MAR-2010 against Rs. 8389 lacs for the quarter ending on 31-MAR-2009.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange regarding an information as per Regulation 13 (3) & (6) of the SEBI (Prohibition of Insider Trading Regulations)1992 in accordance with the intimation received from HDFC Trustee Company Limited on April 12, 2010. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Gsk_Reg_16042010.zip target=NEW> For more details click here.</a>

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange a copy of Notice of the Annual General Meeting to be held on April 23, 2010. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Glaxo_AGMNot_16042010.zip target=NEW> For more details click here.</a>

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange a copy of annual declaration / disclosure form as received from employees of the Company (details as per annexure) under SEBI (Prohibition of Insider Trading) Regulations, 1992.The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/GSK_disc_03022010.zip target=NEW> For more details click here.</a>

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on January 25, 2010 has recommended a Final Dividend at the rate of Rs.18 per equity share of Rs.10 each. Further, the Annual General Meeting is scheduled to be held on April 23, 2010. Further, the Register of Members and Share Transfer Books will remain closed from April 13, 2010 to April 23, 2010, both days inclusive, for the purpose of Dividend and Annual General Meeting.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding the standalone Results for the year ended on 31-DEC-2009 as follows: Net Sales of Rs. 192150 lacs for year ending on 31-DEC-2009 against Rs. 154278 lacs for the year ending on 31-DEC-2008. Net Profit / (Loss) of Rs. 23278 lacs for the year ending on 31-DEC-2009 against Rs. 18833 lacs for the year ending on 31-DEC-2008.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding the standalone Results for the quarter ended on 31-DEC-2009 as follows: Net Sales of Rs. 41812 lacs for quarter ending on 31-DEC-2009 against Rs. 33337 lacs for the quarter ending on 31-DEC-2008. Net Profit / (Loss) of Rs. 3368 lacs for the quarter ending on 31-DEC-2009 against Rs. 3258 lacs for the quarter ending on 31-DEC-2008.

Glaxosmithkline Consumer Healthcare Limited has submitted the Exchange a copy of annual declaration / disclosure form as received from employees of the Company (details as per annexure) under SEBI (Prohibition of Insider Trading) Regulations, 1992.The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/gsk_DIS_22012010.ZIP target=NEW> For more details click here.</a>